$40.15
-0.27-0.67%
Last update: Nov 4, 4:00 PM
Ionis Pharmaceuticals Inc
IONSNASDAQ
The average analyst price target for Ionis Pharmaceuticals is $86.78, 116.1% above the current price. Of 21 analysts, 19 rate it Buy and 2 Hold. Targets range from $46 to $129. The latest change came on Oct 22, 2026, when BMO Capital upgraded Ionis Pharmaceuticals from Market Perform to Outperform and moved its price target from $54 to $66.
Price Target Range — 7 Quarters
Analyst Consensus — 21 Analysts
Rating Trend — Last 9 Months
